However, among patients with EOT-AFP <5.3 ng/mL, the percentage of patients with levels above the upper limit or with a >30% increase in AFP at the onset of HCC were lower in comparison to patients with EOT-AFP ≥5.3 ng/mL (Table 6). The gene discussed is AFP; the disease is hepatocellular carcinoma.